Affiliation:
1. Department of Gynaecological Oncology University Medical Centre Rotterdam Rotterdam the Netherlands
2. Department of Pathology Jeroen Bosch Hospital 's‐Hertogenbosch the Netherlands
3. Department of Public Health, Erasmus MC University Medical Centre Rotterdam Rotterdam the Netherlands
4. Department of Pathology University Medical Centre Rotterdam Rotterdam the Netherlands
Abstract
AbstractBackgroundThe aim of this study was to determine attitude of Dutch midwifes, gynecologists and general practitioners (GPs) towards involvement in antenatal cervical cancer screening (CCS) in the Netherlands.MethodsIn 2021, Dutch midwives, gynecologists, and GPs were offered a single digital questionnaire assessing perceived feasibility, benefits, and harms of antenatal CCS.ResultsA total of 6943 Questionnaires were send and response rate was 18% (N = 1260). Of all respondents, 78% considered antenatal CCS via obstetric care providers feasible. Most respondents (85%) agreed that offering CCS in person can increase motivation to attend. Most midwives (93%) considered that women would feel less encumbered if cervical sampling would be performed by obstetric care providers, rather than by GPs.ConclusionResults indicate that introduction of antenatal CCS is considered feasible by a majority of Dutch midwifes, gynecologists, and GPs. Considered benefits include improved motivation to attend and reduced test related barriers.